{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:37:48Z","timestamp":1787769468996,"version":"build-2784847793"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T00:00:00Z","timestamp":1533600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00432-018-2729-y","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T04:26:45Z","timestamp":1533616005000},"page":"2077-2083","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Stereotactic body radiation therapy for centrally located hepatocellular carcinoma: outcomes and toxicities"],"prefix":"10.1007","volume":"144","author":[{"given":"Stanislav","family":"Lazarev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Hardy-Abeloos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren","family":"Factor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Buckstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,7]]},"reference":[{"key":"2729_CR1","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.1016\/j.ijrobp.2011.04.011","volume":"81","author":"DL Andolino","year":"2011","unstructured":"Andolino DL, Johnson CS, Maluccio M et al (2011) Stereotactic body radiotherapy for primary hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 81:e447\u2013e453","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2729_CR2","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","volume":"31","author":"A Bujold","year":"2013","unstructured":"Bujold A, Massey CA, Kim JJ et al (2013) Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol 31:1631\u20131639","journal-title":"J Clin Oncol"},{"key":"2729_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12094-010-0492-x","volume":"12","author":"HR C\u00e1rdenes","year":"2010","unstructured":"C\u00e1rdenes HR, Price TR, Perkins SM et al (2010) Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clin Transl Oncol 12:218\u2013225","journal-title":"Clin Transl Oncol"},{"key":"2729_CR4","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.ijrobp.2012.09.012","volume":"85","author":"T Eriguchi","year":"2013","unstructured":"Eriguchi T, Takeda A, Sanuki N et al (2013) Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system. Int J Radiat Oncol Biol Phys 85:1006\u20131011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2729_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13014-017-0851-7","volume":"12","author":"E Gkika","year":"2017","unstructured":"Gkika E, Schultheiss M, Bettinger D et al (2017) Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma. Radiat Oncol 12:116","journal-title":"Radiat Oncol"},{"key":"2729_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.radonc.2015.04.006","volume":"115","author":"A Huertas","year":"2015","unstructured":"Huertas A, Baumann AS, Saunier-Kubs F et al (2015) Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma. Radiother Oncol 115:211\u2013216","journal-title":"Radiother Oncol"},{"key":"2729_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/1748-717X-8-250","volume":"8","author":"WI Jang","year":"2013","unstructured":"Jang WI, Kim MS, Bae SH et al (2013) High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma. Radiat Oncol 8:250","journal-title":"Radiat Oncol"},{"key":"2729_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/1471-2407-10-475","volume":"10","author":"JH Kwon","year":"2010","unstructured":"Kwon JH, Bae SH, Kim JY et al (2010) Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer. BMC Cancer 10:475","journal-title":"BMC Cancer"},{"key":"2729_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30:52\u201360","journal-title":"Semin Liver Dis"},{"key":"2729_CR10","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1080\/02841860600897934","volume":"45","author":"A Mendez Romero","year":"2006","unstructured":"Mendez Romero A, Wunderink W, Hussain SM et al (2006) Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase I-II study. Acta Oncol 45:831\u2013837","journal-title":"Acta Oncol"},{"key":"2729_CR11","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ijrobp.2014.11.028","volume":"91","author":"EC Osmundson","year":"2015","unstructured":"Osmundson EC, Wu Y, Luxton G et al (2015) Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract. Int J Radiat Oncol Biol Phys 91:986\u2013994","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"13","key":"2729_CR12","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1002\/cncr.30008","volume":"122","author":"A Takeda","year":"2016","unstructured":"Takeda A, Sanuki N, Tsurugai Y et al (2016) Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation. Cancer 122(13):2041\u20132049","journal-title":"Cancer"},{"key":"2729_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.radonc.2016.10.024","volume":"122","author":"DA Toesca","year":"2017","unstructured":"Toesca DA, Osmundson EC, Eyben RV et al (2017) Central liver toxicity after SBRT: an expanded analysis and predictive nomogram. Radiother Oncol 122:130\u2013136","journal-title":"Radiother Oncol"},{"key":"2729_CR14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1200\/JCO.2007.14.3529","volume":"26","author":"RV Tse","year":"2008","unstructured":"Tse RV, Hawkins M, Lockwood G et al (2008) Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 26:657\u2013664","journal-title":"J Clin Oncol"},{"key":"2729_CR15","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1200\/JCO.2015.61.4925","volume":"34","author":"DR Wahl","year":"2016","unstructured":"Wahl DR, Stenmark MH, Tao Y et al (2016) Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma. J Clin Oncol 34:452\u2013459","journal-title":"J Clin Oncol"},{"key":"2729_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.radonc.2016.07.020","volume":"121","author":"AA Weiner","year":"2016","unstructured":"Weiner AA, Olsen J, Ma D et al (2016) Stereotactic body radiotherapy for primary hepatic malignancies\u2014report of a phase I\/II institutional study. Radiother Oncol 121:79\u201385","journal-title":"Radiother Oncol"},{"key":"2729_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/jrr\/rru130","volume":"56","author":"H Yamashita","year":"2015","unstructured":"Yamashita H, Onishi H, Murakami N et al (2015) Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma. J Radiat Res 56:561\u2013567","journal-title":"J Radiat Res"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-018-2729-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-018-2729-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-018-2729-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T19:12:09Z","timestamp":1565118729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-018-2729-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,7]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["2729"],"URL":"https:\/\/doi.org\/10.1007\/s00432-018-2729-y","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,7]]},"assertion":[{"value":"18 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors of the study have no commercial interests, and no actual, or potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}